Sponsored Links

BRIEF-Idenix Pharma drops in premarket after FDA puts second hepatitis C drug on hold

NEW YORK | Mon Aug 27, 2012 9:09am EDT

NEW YORK Aug 27 (Reuters) - Idenix Pharmaceuticals Inc : * Idenix Pharmaceuticals drops 15 percent to $5.10 in premarket after FDA puts second hepatitis C drug on hold

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.